RENAL AND HEPATIC IMPAIRMENT BROUGHT ON BY CISPLATIN WITHOUT COMPROMISING ANTICANCER EFFICACY. Romanian Journal of Diabetes, Nutrition and Metabolic Diseases, [S. l.], v. 31, n. 1, p. 394–406, 2024. Disponível em: https://jrdiabet.ro/index.php/RJDNMD/article/view/307.. Acesso em: 18 may. 2024.